Health-related quality of life and patient-centred outcomes with COVID-19 vaccination in patients with breast cancer and gynaecological malignancies

INTRODUCTION: Safety and tolerability of COVID-19 vaccines were demonstrated by several clinical trials which led to the first FDA/EMA approvals in 2021. Because of mass immunizations, most social restrictions were waived with effects on quality of life. Therefore, our a-priori hypothesis was that C...

Descripción completa

Detalles Bibliográficos
Autores principales: Forster, Marie, Wuerstlein, Rachel, Koenig, Alexander, Stefan, Alexandra, Wiegershausen, Elisa, Batz, Falk, Trillsch, Fabian, Mahner, Sven, Harbeck, Nadia, Chelariu-Raicu, Anca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602875/
https://www.ncbi.nlm.nih.gov/pubmed/37901314
http://dx.doi.org/10.3389/fonc.2023.1217805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602875/
https://www.ncbi.nlm.nih.gov/pubmed/37901314
http://dx.doi.org/10.3389/fonc.2023.1217805

Ejemplares similares